NIH awards OHSU scientists, collaborators $8.4 million to develop a cure for HIV
Only a handful of people in history have been cured of the virus; three have agreed to kick off landmark research project led by OHSU.
Research
More Research Stories
- Latest Stories
OHSU-developed HIV vaccine tech tested in humans for first time
January 06, 2021
Vir Biotechnology, which licensed OHSU vaccine platform, leads Phase 1 clinical trial.
Actualización Sobre el Ensayo Clínico de OHSU de la Vacuna Contra el COVID-19
December 14, 2020
Individuals who have high risk for infection are being prioritized for enrollment into national study.
OHSU COVID-19 Vaccine Clinical Trial Update
December 14, 2020
Individuals who have high risk for infection are being prioritized for enrollment into national study.
NBA ‘bubble’ reveals the ultimate home court advantage, study finds
December 11, 2020
OHSU study highlights the importance of paying attention to circadian rhythms.
Long-term study of mitochondrial replacement therapy in monkeys finds no adverse health effects
December 08, 2020
Findings add safety, efficacy support for gene therapy developed at OHSU.
Damage to brain cells reverberates to ‘bystander’ cells, study finds
December 08, 2020
OHSU scientists are first to document mechanism that can cause temporary but severe loss of nervous system function.
OHSU physician honored for co-invention of eye-imaging technology
December 04, 2020
David Huang, M.D., Ph.D., recognized by Sanford and Susan Greenberg Prize to End Blindness.
New review confirms disproportionate impact of COVID-19 on Black, Hispanic populations
December 03, 2020
Primary factor is heightened risk of exposure, transmission.
Local couples join male birth control study at OHSU
December 03, 2020
NES/T gel may expand contraceptive options, shared family planning responsibility.
Acclaimed OHSU HIV researcher appointed to COVID-19 vaccine review group
December 03, 2020
Gov. Kate Brown has named Louis Picker, M.D., to the Western States’ Scientific Safety Review Workgroup.